Jan. 24–28, 2022 • Virtual
Registration Rates | 2022 Program Schedule | Meeting Code of Conduct
OVERVIEW
The safety of our attendees at our in-person and hybrid events are of the utmost importance at the Society for Immunotherapy of Cancer (SITC). Given the recent increase in the COVID-19 virus and the Omicron variant, the SITC has made the decision to convert the upcoming Cancer Immunotherapy Winer School to a fully virtual program, and will continue to be held on Jan. 24–28, 2022, to ensure the safety of our attendees.
Through the fully virtual program attendees will access the best in cancer immunotherapy education taught by leading experts in the field. This program will provide a deep understanding of the core principles of tumor immunology and cancer immunotherapy as well as developing areas in the field including biomarker technology, validation and clinical integration; clinical trial design, data analysis and considerations for combination therapies. The virtual program will cover the same content as the original hybrid program. View the full program schedule here.
The program is tailored to early-to-mid career scientists and clinicians in the field of cancer immunotherapy working in academic, clinical, industry and government settings as well as those new to the field. The curriculum covers the fundamentals of cancer immunotherapy and features separate tracks, including clinical and research, allowing participants to tailor their experience by selecting the educational path most relevant to their learning goals.
ORGANIZERS
- Catherine Bollard, MBChB, MD – Children’s National Hospital
- Christian Capitini, MD – University of Wisconsin-Madison
- Daniel Powell, PhD – University of Pennsylvania
Target Audience
- Early-to-mid career scientists in the field of cancer immunotherapy working in academic, clinical, industry and government settings
- Individuals new to the field working in academic, clinical, industry and government settings
NETWORKING OPPORTUNITIES
In addition to deepening their understanding of integral facets of the field of cancer immunotherapy, attendees will have virtual opportunities to expand their professional network, developing new relationships with faculty and other thought leaders through small group breakout sessions and virtual networking features.
LEARNING OBJECTIVES
Upon completion of the Cancer Immunotherapy Winter School, participants will be able to:
- Describe the core principles of tumor immunology and cancer immunotherapy
- Discuss recent advancements in drug and biomarker technologies and their clinical application
- Explain appropriate clinical and/or preclinical trial data analysis methods and best practices in clinical and/or preclinical trial design
Young Investigator Award Recipients
To support young investigators and clinicians interested in attending the Cancer Immunotherapy Winter School, SITC is pleased to offer applications for travel awards, which will supplement costs for those honored to attend.
Congratulations to the recipients of the 2022 Winter School Travel Awards:
- Muna Abdalla, MS – University of Tours
- Aileen Fernandez, PhD, MS – Yale University of Medicine
- Cassandra Gilmour, PhD Candidate – Cleveland Clinic Lerner College of Medicine
- Katherine Sanchez, MD – Baylor College of Medicine
- Michael Serzan, MD – Georgetown Lombardi Comprehensive Cancer Center
Continuing Education Credits
Continuing Education Credits are available for Cancer Immunotherapy Winter School attendees. Click here for more information.